Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
3
×
boston
boston blog main
boston top stories
clinical trials
life sciences
national top stories
aldehyde
aldeyra therapeutics
alexion pharmaceuticals
allergic conjunctivitis
alnylam pharmaceuticals
angel investors
arboretum ventures
biotech
boehringer ingelheim
cultivation capital
deals
detroit
detroit blog main
detroit top stories
dicerna pharamceuticals
drugs
dry eye disease
entrepreneurship
fda
fifth eye
funding
healthtech
heart monitor
hemodynamic instability
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
innovation
invest michigan
jen baird
menlo innovations
michigan pre-seed fund ii
patisiran
What
eye
3
×
drug
fda
new
aldeyra
ann
announced
approval
arbor
based
capital
caught
causing
closer
data
developed
dicerna
disclosed
disease
fifth
fighting
filing
gene
hepatitis
inflammation
intended
medical
medicine
medicines
michigan
multiple
pay
pharma
pharmaceuticals
phase
positive
prepares
producing
protein
puts
Language
unset
Current search:
eye
×
" national blog main "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug